Live Breaking News & Updates on Brighton collaboration

Stay updated with breaking news from Brighton collaboration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

Saimbarashe Takuva, Azwi Takalani, and colleagues investigate the frequency and incidence of adverse events reported after receipt of a single dose of the Ad26.COV2.S COVID-19 vaccine among health care workers in South Africa.

South-africa , United-states , Tanzania , Takalani , Limpopo , Tanzanian , South-african , Amitabh-bipin-suthar , Nivashnee-naicker , Phuthi-mohlala , Dorothea-urbach , James-craig-innes

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

In a recent study, researchers analyzed the incidence of myocarditis among COVID-19 mRNA-1273 vaccinees.

Brighton , Brighton-and-hove , United-kingdom , Australia , Canada , Switzerland , Swiss , Centers-for-disease , World-health-organization , Uppsala-monitoring-centre , Clinical-infectious-diseases

Who is Responsible for Vaccine Safety?

Vaccine benefits and risks are not always straightforward

Boston , Massachusetts , United-states , Washington , C-corey-hardin , Centers-for-disease , School-vaccine-requirements , Drug-administration , Precision-vaccinations , Reviews-editor , New-england-journal

Low risk of second allergic reaction after SARS-CoV-2 vaccination

In a recent investigation posted to the journal JAMA Internal Medicine,* researchers estimate the risk of a repeated allergic reaction to the second severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine dose in those with a history of allergic responses following the first dose by conducting a systematic review and meta-analysis.

Rido-shutterstock , World-allergy-organization , National-institute-of-allergy , World-health-organization , Second-allergic-reaction , Systematic-review , Image-credit , Global-cov , Brighton-collaboration , National-institute , Infectious-diseases

Is the COVID-19 Vaccine Ethical for Christians? (Part 2 - Is it Safe?)

Read Is the COVID-19 Vaccine Ethical for Christians? (Part 2 - Is it Safe?) by Dr. Terrill Wade and more articles, devotionals and current events stories on COVID-19

China , Brighton , Brighton-and-hove , United-kingdom , South-africa , Australia , United-states , Russia , Britain , America , Terrill-wade , Gettyimages-joaopauloburini

Longer Time Between COVID mRNA Doses May Cut Myocarditis Risk

A Canadian study that has not yet been peer-reviewed suggests inter-dose interval and vaccine schedule combinations may play a role in the risk for myocarditis or pericarditis.

Canada , Toronto , Ontario , Canadian , Jeffreyc-kwong , Canadian-immunization-research-network , University-of-toronto-on-medrxiv , Canadian-institutes-of-health-research , University-of-toronto , Ontario-ministry-of-health , Public-health-agency-of-canada

CDC study shows risk of Guillain-Barré syndrome elevated after Ad.26.COV2.S COVID vaccination

Researchers compile available data from the interim analysis of the number of cases of GBS and the risks posed by different vaccines.

Colorado , United-states , California , Washington , Denver , Palsand-shutterstock , Kaiser-permanente , Pfizer , Denver-health , International-classification-of-diseases , Us-centers-for-disease , Drug-administration

Receipt of mRNA Vaccine against Covid-19 and Myocarditis

Receipt of mRNA Vaccine against Covid-19 and Myocarditis
nejm.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nejm.org Daily Mail and Mail on Sunday newspapers.

Israel , Dallas , Texas , United-states , Israeli , Centers-for-disease , Pfizer , Clalit-health-services , World-health-organization , Israeli-ministry-of-health , World-health

Adverse events following immunisation with COVID-19 vaccines: Safety Report #33 – 16 October 2021

There were 2,512 non-serious and 61 serious reports this week

Otago , New-zealand , New-zealanders , Biontech-comirnaty , Pfizer , University-of-otago , Ministry-of-health , Centre-for-adverse-reactions-monitoring , Safety-report , Adverse-reactions-monitoring , Pacific-peoples , New-zealand-european

Guillain-Barre Risk Up Slightly After Shingrix

Findings support FDA warning for recombinant zoster vaccine

Silver-spring , Maryland , United-states , Portland , Oregon , Ravi-goud , Judy-george , Dennis-bourdette , Science-university-in-portland , Oregon-health , Research-in-silver-spring , Biologics-evaluation